Back to Authors

Liu, Jianzhong

0000-0001-7826-7045

A5100693289 | I2948539688

Mayo Clinic

AbbVie (United States)

Citations 3

S909 Efficacy of Upadacitinib in Patients With Crohn’s Disease Activity Index-Based Eligibility Criteria: Post Hoc Analysis of U-EXCEL, U-EXCEED, and U-ENDURE Phase 3 Trials

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S678-S679

10.14309/01.ajg.0000953276.85317.47

Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease

New England Journal of Medicine | May 24, 2023 | Volume: 388 | Issue: 21 | Pages: 1966-1980

10.1056/nejmoa2212728 | PMID 37224198

S0643 Composite and Individual Measures of Efficacy and Safety of Upadacitinib Treatment for Crohn's Disease: 12-Month Results From the Ongoing Phase 2 CELEST Open-Label Extension Study

American Journal of Gastroenterology | October 24, 2020 | Volume: 115 | Issue: 1 | Pages: S322-S323

10.14309/01.ajg.0000704620.03018.6c